Screening of Tuberculosis patients for possible diabetes mellitus in India: a systematic review
Egyptian Journal of Bronchology volume 11, pages 1–6 (2017)
Tuberculosis (TB) and diabetes mellitus (DM) are both the greatest public health problems in the world. Although India ranks fourth in TB burden, the incidence of diabetes in the country is also rising. The bidirectional association between TB and DM is established by many epidemiological studies elsewhere in the world.
The aim of this study was to understand the utility and importance of screening patients with TB for possible DM in Indian settings through systematic literature review.
For the search of articles, PubMed and Google Scholar search engines were primarily used. Few articles were also obtained from the cross-references of the selected articles. Of 108 articles obtained by the end of this search process, eight full-texts articles were finally selected for the purpose of this review.
Of the eight titles, six articles focused on screening of patients with TB for DM (unidirectional screening), whereas two articles focused on bidirectional screening, that is, screening of patients with TB for DM and vice versa. Of the eight studies obtained, six studies are from South Indian states (Andhra Pradesh, Tamil Nadu, and Karnataka), one from West Indian state (Gujarat), and one covers pan-India sample. The prevalence of DM among patients with TB ranged from 2.9% (lowest) to 21.2% (highest). Similarly, the number needed to screen ranged from 16 (lowest) to 40 (highest) as reported by various studies conducted in India.
Screening of patients with TB for DM is feasible at the level of existing health system without any additional resources as demonstrated by the studies conducted in different parts of India.
Chang JT, Dou HY, Yen CL, Wu YH, Huang RM, Lin HJ, et al. Effect of type 2 diabetes mellitus on the clinical severity and treatment outcome in patients with pulmonary tuberculosis: a potential role in the emergence of multidrug-resistance. J Formos Med Assoc 2011; 110:372–381.
Restrepo BI. Convergence of the tuberculosis and diabetes epidemics: renewal of old acquaintances. Clin Infect Dis 2007; 45:436–438.
Baghaei P, Marjani M, Javanmard P, Tabarsi P, Masjedi MR. Diabetes mellitus and tuberculosis facts and controversies. J Diab Metab Disord. 2013; 12:1.
Goldhaber-Fiebert JD, Jeon CY, Cohen T, Murray MB. Diabetes mellitus and tuberculosis in countries with high tuberculosis burdens: individual risks and social determinants. Int J Epidemiol 2011; 40:dyq238.
Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med 2008; 5:e152.
Dobler CC, Flack JR, Marks GB. Risk of tuberculosis among people with diabetes mellitus: an Australian nationwide cohort study. BMJ Open 2012; 2:e000666.
Young F, Critchley JA, Johnstone LK, Unwin NC. A review of co-morbidity between infectious and chronic disease in Sub Saharan Africa: TB and diabetes mellitus, HIV and metabolic syndrome, and the impact of globalization. Global Health 2009; 5:1.
Dooley KE, Chaisson RE. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis 2009; 9:737–746.
Deshmukh PA, Shaw T. Pulmonary tuberculosis and diabetes mellitus. Ind J Tub 1984; 31:114.
Jeon CY, Harries AD, Baker MA, Hart JE, Kapur A, Lonnroth K, et al. Bi-directional screening for tuberculosis and diabetes: a systematic review. Trop Med Int Health 2010; 15:1300–1314.
Balde NM, Camara A, Camara LM, Diallo MM, Kake A, Bah-Sow OY. Associated tuberculosis and diabetes in Conakry, Guinea: prevalence and clinical characteristics. Int J Tuberc Lung Dis 2006; 10:1036–1040.
Singh MM, Biswas SK, Ashok S, Ashok KR, Singh PP. Impaired glucose tolerance in active pulmonary tuberculosis. Ind J Tub 1984; 31:118–121.
Greenhalgh T. Assessing the methodological quality of published papers. BMJ: Br Med J 1997; 315:305.
Shidam UG, Roy G, Sahu SK, Kumar SV, Ananthanarayanan PH. Screening for diabetes among presumptive tuberculosis patients at a tertiary care centre in Pondicherry, India. Int J Tuberc Lung Dis 2015; 19:1163–1168.
Achanta S, Tekumalla RR, Jaju J, Purad C, Chepuri R, Samyukta R, et al. Screening tuberculosis patients for diabetes in a tribal area in South India. Public Health Action 2013; 3(Suppl 1): S43–S47.
Naik B, Kumar AM, Satyanarayana S, Suryakant MD, Swamy NM, Nair S, et al. Is screening for diabetes among tuberculosis patients feasible at the field level? Public Health Action 2013; 3(Suppl 1): S34–S37.
Dave P, Shah A, Chauhan M, Kumar AM, Harries AD, Malhotra S, et al. Screening patients with tuberculosis for diabetes mellitus in Gujarat, India. Public Health Action 2013; 3(Suppl 1): S29–S33.
Prakash BC, Ravish KS, Prabhakar B, Ranganath TS, Naik B, Satyanarayana S, et al. Tuberculosis-diabetesmellitus bidirectional screening at a tertiary care centre, South India. Public Health Action 2013; 3(Suppl 1): S18–S22.
Kumpatla S, Aravindalochanan V, Rajan R, Viswanathan V, Kapur A. Evaluation of performance of A1c and FPG tests for screening newly diagnosed diabetes defined by an OGTT among tuberculosis patients-a study from India. Diabetes Res Clin Pract 2013; 102:60–64.
Jali MV, Mahishale VK, Hiremath MB. Bidirectional screening of tuberculosis patients for diabetes mellitus and diabetes patients for tuberculosis. Diabetes Metab J 2013; 37:291–295.
India Tuberculosis-Diabetes Study Group. Screening of patients with tuberculosis for diabetes mellitus in India. Trop Med Int Health 2013; 18:636–645.
Stop TB. World Health Organization, International Union against Tuberculosis and Lung Disease. Provisional collaborative framework for care and control of tuberculosis and diabetes. WHO/HTM/TB/ 2011.15. Geneva, Switzerland: WHO, The Union, 2011. Available at: http://whqlibdoc.who.int/publications/2011/9789241502252_eng.pdf. [Accessed 2 September 2016]
International Expert Committee. International expert committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009; 32:1327–1334.
Kumar PR, Bhansali A, Ravikiran M, Bhansali S, Dutta P, Thakur JS, et al. Utility of glycated hemoglobin in diagnosing type 2 diabetes mellitus: a community-based study. J Clin Endocrinol Metab. 2010; 95:2832–2835.
World Health Organization. Use of glycated hemoglobin (HbA1c) in the diagnosis of diabetes mellitus: abbreviated report of a WHO consultation. WHO/NMH/CHP/CPM/11.1. Geneva, Switzerland: WHO; 2011. Available at: http://www.who.int/cardiovascular_diseases/reporthba1c_2011_edited.pdf. [Accessed 5 September 2016]
International Diabetes Federation. IDF Diabetes atlas, 5th ed. International Diabetes Federation, Brussels. 2011. Available at: http://www.eatlas.idf.org. [Accessed 10 September 2016]
World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Geneva, Switzerland: Summary of Technical Report and Recommendations; 2006.
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
About this article
Cite this article
Samal, J. Screening of Tuberculosis patients for possible diabetes mellitus in India: a systematic review. Egypt J Bronchol 11, 1–6 (2017). https://doi.org/10.4103/1687-8426.199003
- disease control